US Bancorp DE Decreases Stock Holdings in BridgeBio Pharma, Inc. (NASDAQ:BBIO)
US Bancorp DE reduced its stake in BridgeBio Pharma, Inc. (NASDAQ:BBIO – Free Report) by 55.1% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 4,455 shares of the company’s stock after selling 5,462 shares during the quarter. US Bancorp DE’s holdings in BridgeBio Pharma […]
